T 1343/19 (Low frequency glatiramer acetate therapy/YEDA) of 10.09.2020
- European Case Law Identifier
- ECLI:EP:BA:2020:T134319.20200910
- Date of decision
- 10 September 2020
- Case number
- T 1343/19
- Petition for review of
- -
- Application number
- 15171065.4
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Low frequency glatiramer acetate therapy
- Applicant name
- Yeda Research & Development Company, LTD.
- Opponent name
- Generics [UK] Limited (trading as Mylan)
Synthon B.V.
Alvogen IPCo S.a.r.l.
G. L. Pharma GmbH
Hexal AG
Mylan Teoranta Trading as Mylan Institutional - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56 (2007)
- Keywords
- Main (sole) request: inventive step - (no)
- Catchword
- -
- Cited cases
- -
Order
For these reasons it is decided that:
1. The decision under appeal is set aside.
2. The patent is revoked.